Dognosis: AI and Dogs Detecting Cancer Early

From Bengaluru comes a startup shaking up cancer screening with a canine twist. The tech leverages dogs’ nostrils—yes, you read that right—and artificial intelligence (AI) for a scent-based diagnosis.

The Sequencing of Sniffers

Dognosis is an Indian startup focusing on a unique, non-invasive method of cancer screening. The startup leverages dogs’ heighted sense of smell and integrates it with AI. The procedure is simple, as patients just breathe into a mask for 10 minutes. This exhaled breath undergoes chemical analysis to detect any alterations in metabolism. This results in the exhalation of tiny molecules known as volatile organic compounds (VOCs). These molecules are difficult to detect by humans, but dogs have 300 million scent receptors. This enables them to detect these subtle changes efficiently. The company integrates AI into the system, making it an unbiased tool. This is because Dognosis uses EEG sensors to track a dog’s brainwaves and sniffing movements. AI algorithms translate these data points into an objective cancer risk score. This duo — dogs and AI — is a departure from traditional methods of biopsies or expensive radiation scanners. Dogs sniff for the type of molecules that indicate cancer, and the AI formulates this intuitive process into medical data. The team has clinical trials showing 90% accuracy. This clears the path for a commercial launch by 2027. This makes it an affordable and accessible alternative to conventional methods.

A Million Dollar Dognosis

Startups enter the medical field to disrupt the market but often they do it with innovative medical devices. Nothing can be closer to reality than this case. Dognosis has successfully raised 2 million in seed funding from some of the best investors. While the company chooses to keep its current valuation under wraps, it is an exciting foray into digitizing canine biology. The company successfully transforms a simple process of sniffing into a medical breakthrough. In fact, Dognosis is a reminder that breakthroughs often come from repurposing existing tools rather than inventing everything.

Where Dogs and AI Merge

The Process of Investigating Aroma

cancer cells alter metabolism, producing distinct VOCs. Dogs excelling in smell can be trained to identify these molecules in a person’s breath. Once a dog detects VOCs, AI calculates the extent of risk using the electrical signals from the brain. The EEG sensors track this brain activity so that the AI does not show any bias towards the handler.

Getting To Know The Dog

Experiments show that dogs have a far superior sense of smell. Dogs have about 300 million receptors while humans have only 6 million. Dogs do not interpret their smelling abilities in terms of human bias. Hence, AI comes to the picture. Dognosis takes this advantage further by using EEG sensors. EEG sensors track the brainwaves and minute sniffing movements, which let AI calculate an objective cancer risk score. The company’s founders are an unconventional duo—cognitive scientist from Berkeley and a military canine trainer.

How Accurate is Dognosis?

Dognosis has been met with optimism due to its high accuracy rate of 90%. These are the results of trials where the data was collected from dogs and AI. This is also a testament to the company’s potential. Currently, Dognosis continues clinical trials and aims for a commercial launch by 2027.

Reimagining a Cost-Effective Cancer Screening

Those who do not have easy access to advanced hospitals will benefit from Dognosis. Cancer screenings will be easily accessible and affordable. This means that patients will no longer need to go through painful biopsies or expensive radiation scanning machines. What’s more, it will be quick to implement. Clinics will be able to detect cancer early. An accurate early detection will lead to an increase in the survival rate. Hence, it will also be a cost-effective alternative to the existing methods. Early diagnosis could lead to preventive measures and less expensive treatments. Patients will have a peace of mind as a result of the non-invasive diagnostic method. This will drastically change the cancer diagnosis process. The company’s main aim is to save a million lives. This will be realized primarily as a result of the combination of biology, artificial intelligence and one of nature’s most powerful sensors. The concept of Dognosis is not limited to dogs, but combines biology, artificial intelligence and one of the most powerful sensors ever. The company combines case studies of dogs sniffing out cancer to make an early diagnosis. Practically, this will change the cancer diagnosis process in a significant and positive way.